BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2370566)

  • 1. Monitoring of phenytoin in epileptic children: value of the single morning sample.
    Naglo AS; Nergårdh A; Boréus LO
    J Neurol; 1990 Jun; 237(3):186-90. PubMed ID: 2370566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of phenytoin protein binding in epileptic patients.
    DeMonaco HJ; Lawless LM
    Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
    Bielmann P; Levac T
    Eur J Clin Pharmacol; 1978 Nov; 14(3):191-4. PubMed ID: 729613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy.
    Norell E; Lilienberg G; Gamstorp I
    Eur Neurol; 1975; 13(3):232-44. PubMed ID: 807479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.
    Schmidt D; Haenel F
    Neurology; 1984 Sep; 34(9):1252-5. PubMed ID: 6540414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.
    Haidukewych D; Rodin EA
    Ther Drug Monit; 1981; 3(3):303-7. PubMed ID: 6798720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phenytoin during pregnancy, labor and puerperium.
    Bardy AH; Hiilesmaa VK; Teramo KA
    Acta Neurol Scand; 1987 Jun; 75(6):374-5. PubMed ID: 3630633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of drug therapy in epileptic children.
    Singh LM; Mehta S; Vohra RM; Nain CK
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response in epilepsy in relation to total and free serum levels of phenytoin.
    Peterson GM; Khoo BH; von Witt RJ
    Ther Drug Monit; 1991 Sep; 13(5):415-9. PubMed ID: 1957333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
    May TW; Rambeck B; Nothbaum N
    Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.
    Schmidt D; Einicke I; Haenel F
    Arch Neurol; 1986 Mar; 43(3):263-5. PubMed ID: 3947275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum phenytoin concentration and clinical response in patients with epilepsy.
    Gannaway DJ; Mawer GE
    Br J Clin Pharmacol; 1981 Dec; 12(6):833-9. PubMed ID: 7340885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effectiveness of two oral phenytoin products and chronopharmacokinetics of phenytoin.
    Petker MA; Morton DJ
    J Clin Pharm Ther; 1993 Jun; 18(3):213-7. PubMed ID: 8345007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N; Kabra M; Gulati S; Gupta YK; Pandey RM; Bhatia BD
    BMC Pediatr; 2016 May; 16():66. PubMed ID: 27179628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin and IgA concentrations in plasma and saliva in epileptic children.
    Modéer T; Tomson G; Falk O; Rane A
    Acta Paediatr Scand; 1981; 70(3):373-8. PubMed ID: 7246128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.